A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors

NCT07318805 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

260

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer
Metastatic Breast Cancer (HR+/ HER2-)
Colorectal Cancer
Metastatic Colorectal Adenocarcinoma
Triple Negative Breast Cancer

Interventions

DRUG: PF-08032562
DRUG: Fulvestrant
DRUG: Cetuximab
DRUG: Fluorouracil
DRUG: Oxaliplatin
DRUG: Leucovorin
DRUG: Bevacizumab

Sponsor

Pfizer